Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis

被引:33
|
作者
Guidozzi, Nadia [1 ]
Wiggins, Tom [1 ]
Ahmed, Ahmed R. [1 ]
Hanna, George B. [1 ]
Markar, Sheraz R. [1 ]
机构
[1] Imperial Coll London, Dept Surg & Canc, London, England
关键词
fundoplication; gastroesophageal reflux disease; magnetic sphincter augmentation; NISSEN FUNDOPLICATION; MANAGEMENT-SYSTEM; OUTCOMES; COMPLICATIONS; MULTICENTER; TRIAL;
D O I
10.1093/dote/doz031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Magnetic sphincter augmentation (MSA) has been proposed as a less invasive, more appealing alternative intervention to fundoplication for the treatment of gastroesophageal reflux disease (GERD). The aim of this study was to evaluate clinical outcomes following MSA for GERD control in comparison with laparoscopic fundoplication. A systematic electronic search for articles was performed in Medline, Embase, Web of Science, and Cochrane Library for single-arm cohort studies or comparative studies (with fundoplication) evaluating the use of MSA. A random-effects meta-analysis for postoperative proton pump inhibitor (PPI) use, GERD-health-related quality of life (GERD-HRQOL), gas bloating, ability to belch, dysphagia, and reoperation was performed. The systematic review identified 6 comparative studies of MSA versus fundoplication and 13 single-cohort studies. Following MSA, only 13.2% required postoperative PPI therapy, 7.8% dilatation, 3.3% device removal or reoperation, and esophageal erosion was seen in 0.3%. There was no significant difference between the groups in requirement for postoperative PPI therapy (pooled odds ratio, POR = 1.08; 95%CI 0.40-2.95), GERD-HRQOL score (weighted mean difference, WMD= 0.34; 95%CI -0.70-1.37), dysphagia (POR = 0.94; 95%CI 0.57-1.55), and reoperation (POR = 1.23; 95%CI 0.26-5.8). However, when compared to fundoplicationMSA was associated with significantly less gas bloating (POR = 0.34; 95%CI 0.16-0.71) and a greater ability to belch (POR = 12.34; 95%CI 6.43-23.7). In conclusion, magnetic sphincter augmentation achieves good GERD symptomatic control similar to that of fundoplication, with the benefit of less gas bloating. The safety of MSA also appears acceptable with only 3.3% of patients requiring device removal. There is an urgent need for randomized data directly comparing fundoplication with MSA for the treatment of GERD to truly evaluate the efficacy of this treatment approach.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Short-Term Outcomes Using Magnetic Sphincter Augmentation Versus Nissen Fundoplication for Medically Resistant Gastroesophageal Reflux Disease
    Louie, Brian E.
    Farivar, Alexander S.
    Shultz, Dale
    Brennan, Christina
    Vallieres, Eric
    Aye, Ralph W.
    ANNALS OF THORACIC SURGERY, 2014, 98 (02): : 498 - 505
  • [22] Laparoscopic fundoplication for gastroesophageal reflux disease
    Frazzoni, Marzio
    Piccoli, Micaela
    Conigliaro, Rita
    Frazzoni, Leonardo
    Melotti, Gianluigi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (39) : 14272 - 14279
  • [23] Laparoscopic fundoplication for gastroesophageal reflux disease
    Marzio Frazzoni
    Micaela Piccoli
    Rita Conigliaro
    Leonardo Frazzoni
    Gianluigi Melotti
    World Journal of Gastroenterology, 2014, (39) : 14272 - 14279
  • [24] Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis
    Blozik, Eva
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014, 28 (07): : 2249 - 2249
  • [25] Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis
    Eva Blozik
    Surgical Endoscopy, 2014, 28 : 2249 - 2249
  • [26] Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis
    Nadja Rickenbacher
    Thomas Kötter
    Michael M. Kochen
    Martin Scherer
    Eva Blozik
    Surgical Endoscopy, 2014, 28 : 143 - 155
  • [27] Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis
    Rickenbacher, Nadja
    Koetter, Thomas
    Kochen, Michael M.
    Scherer, Martin
    Blozik, Eva
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014, 28 (01): : 143 - 155
  • [28] CLINICAL EFFICACY OF TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) IN REFRATORY GASTROESOPHAGEAL REFLUX DISEASE (GERD) - A SYSTEMATIC REVIEW & COMPARATIVE META-ANALYSIS WITH MAGNETIC SPHINCTER AUGMENTATION (MSA)
    Chandan, Saurabh
    Mohan, Babu P.
    Khan, Shahab R.
    Canakis, Andrew
    Malik, Sarah
    Jha, Lokesh K.
    Bhat, Ishfaq
    Hewlett, Alexander
    Sharma, Neil R.
    Adler, Douglas G.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB119 - AB120
  • [29] Safety profile of magnetic sphincter augmentation for gastroesophageal reflux disease
    Froiio, Caterina
    Aiolfi, Alberto
    Bona, Davide
    Bonavina, Luigi
    FRONTIERS IN SURGERY, 2023, 10
  • [30] The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease
    Bonavina, Luigi
    Boyle, Nick
    Schoppmann, Sebastian F.
    CURRENT OPINION IN GASTROENTEROLOGY, 2021, 37 (04) : 384 - 389